3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone CAS:272778-12-8

3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone exhibits promising characteristics for various biomedical applications, particularly in pharmaceutical research and drug development. Key areas of interest include: Antibacterial Activity: It shows potent antibacterial properties against Gram-positive pathogens, making it a potential candidate for new antibiotics targeting resistant strains. Antimicrobial and Antifungal Properties: The compound demonstrates effectiveness against fungi and certain resistant microbial strains, contributing to the exploration of new antimicrobial agents. Pharmacological Studies: Research focuses on its pharmacokinetics and pharmacodynamics to understand its efficacy and safety profile in potential clinical use. Structure-Activity Relationship (SAR) Studies: Its complex structure provides insights into SAR, aiding in the design and optimization of novel pharmaceuticals with improved therapeutic profiles. 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone represents a frontier in medicinal chemistry, offering potential solutions to challenges posed by antimicrobial resistance and underscoring its role in future drug discovery efforts. Ongoing research endeavors aim to elucidate further applications and refine its therapeutic capabilities.